US Patent 7579488 Vitamin D receptor modulators
Patent 7579488 was granted and assigned to Eli Lilly and Company on August, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+280 characters)
Article
Patent abstract
The present invention relates to novel, non-secosteroidal, phenyl-benzofuran compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1α,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 17 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07579488 Vitamin D receptor modulators US Patent 7579488 Vitamin D receptor modulators
Infobox
Patent Number
0757948800
Patent Number
757948800
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075794880
Date of Patent
August 25, 2009
0Patent Application Number
105795630
Date Filed
November 16, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075794880
Date of Patent
August 25, 2009
0Patent Application Number
105795630
Date Filed
November 16, 2004
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07579488 Vitamin D receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07579488
Date of patent
August 25, 2009
Patent application number
10579563
Date Filed
November 16, 2004
Patent primary examiner
Find more entities like US Patent 7579488 Vitamin D receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
